Jaguar Health, Inc. (JAGX)

1.19 -0.05 (-4.03%) USD  |  NASDAQ  |  Dec 17, 16:00
1.19 0.00 (0.00%) After-Hours: 18:38
More

Jaguar Health Research and Development Expense (Quarterly): 3.658M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for JAGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. 3.552B
GeoVax Labs, Inc. 5.044M
Moderna, Inc. 749.00M
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. 2.526M